Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)
Sponsor: Merck Sharp & Dohme LLC
Summary
This goal of this trial is to learn about two medicines, enlicitide and rosuvastatin, in healthy people. Researchers will compare the amounts of enlicitide and rosuvastatin in a person's body over time, when they are given as separate medicines and when they are combined into one tablet.
Official title: A Clinical Study to Evaluate the Relative Bioavailability of FDC Tablets Containing Enlicitide and Rosuvastatin, Compared to Enlicitide and Rosuvastatin Administered Concomitantly as Single Entities, in Healthy Adult Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-12-29
Completion Date
2026-07-22
Last Updated
2026-03-18
Healthy Volunteers
Yes
Conditions
Interventions
MK-0616A
Enlicitide/rosuvastatin fixed dose combination (FDC) or enlicitide/rosuvastatin FDC formulation B oral tablets
Enlicitide
Oral tablet
Rosuvastatin
Oral tablet
Locations (1)
Celerion ( Site 0001)
Tempe, Arizona, United States